| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/04/2002 | US20020086842 Method for transfecting cells using a magnetic field |
| 07/04/2002 | US20020086839 Inhibitors of DNA immunostimulatory sequence activity |
| 07/04/2002 | US20020086837 Acne vaccine |
| 07/04/2002 | US20020086836 Cftr gene regulator |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086827 RANK (receptor activator of neurotrophic factor-kappa B) polypeptides; immunoregulatory activity |
| 07/04/2002 | US20020086826 Antibodies against ligand for receptor activator of NF-kB |
| 07/04/2002 | US20020086822 Nucleic acids, proteins, and antibodies |
| 07/04/2002 | US20020086817 Mannan-binding protein or gene; vaccinia virus vectors |
| 07/04/2002 | US20020086813 Mutants of streptococcal toxin a and methods of use |
| 07/04/2002 | US20020086812 Gene expression inhibition; for treatment of cancer of pancreas, lungs, prostates, livers, ovaries, cervices, and/or breasts; drug delivery |
| 07/04/2002 | US20020086444 Isolated menbrane protein for use in the diagnosis and treatment of alzheimer's disease |
| 07/04/2002 | US20020086428 Controlling nucleotide sequence propagaton cells; obtain cells, transform with preferential expression vectors, monitor cell for preferential expression |
| 07/04/2002 | US20020086427 Inducible eukaryotic expression system that regulates protein translation |
| 07/04/2002 | US20020086426 Controlling gene expression; obtain cell, transform with expression vector, transcribe and monitor generation of tetracycline |
| 07/04/2002 | US20020086420 Novel antiangiogenic peptides |
| 07/04/2002 | US20020086419 Episomal vector and uses thereof |
| 07/04/2002 | US20020086417 Apparatus for use in th analysis of nucleotide sequences |
| 07/04/2002 | US20020086416 Device for use in the detection, separation and analysis of nucleotide sequences |
| 07/04/2002 | US20020086414 Novel ctla4/cd28 ligands and uses therefor |
| 07/04/2002 | US20020086413 LktA deletion mutant of P. haemolytica |
| 07/04/2002 | US20020086412 Generating preferential bacteria; obtain genetically engineered bacteria sample, inoculate nutrient broth, propagate, express genes, recover heterologous products |
| 07/04/2002 | US20020086411 Defective adenovirus for use in the treatment of tumors |
| 07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
| 07/04/2002 | US20020086407 Enzymatic polypeptide; for use in the treatment of eating, kidney, diabetic, urogenital, septic, glandular, cachexia and cancer |
| 07/04/2002 | US20020086404 Nucleotide sequences coding for the luxR gene |
| 07/04/2002 | US20020086403 Polypeptide for use in the treatment and prevention of viral infections and cancer |
| 07/04/2002 | US20020086402 Hyperthermostable protease gene |
| 07/04/2002 | US20020086401 Nucleotide sequences coding transport protein; for use generating antiproliferative agents |
| 07/04/2002 | US20020086398 Nucleotide sequences coding enzymatic polypeptide for us ein bioremediation and pollution control |
| 07/04/2002 | US20020086397 Glycosyl hydrolase genes and their use for producing enzymes for the biodegradation of carrageenans |
| 07/04/2002 | US20020086393 Mitochondrial adenylate kinase |
| 07/04/2002 | US20020086388 N-end rule pathway enzymes |
| 07/04/2002 | US20020086387 23155 novel protein human 5-alpha reductases and uses therefor |
| 07/04/2002 | US20020086386 B-catenin assays, and compositions therefrom |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086380 Enzymatic polypeptide for use in animal feeds and in generating chemical intermediates for vitamin A |
| 07/04/2002 | US20020086379 Human membrane-spanning proteins |
| 07/04/2002 | US20020086374 Polynucleotide coding transport protein for use in generation of preferential amino acids |
| 07/04/2002 | US20020086372 Nucleotide sequences coding enzymatic polypeptide for use in generating lysine; for use in animal feeds, human medicine and pharmacology |
| 07/04/2002 | US20020086371 Microorganism for use in the generation of lysine; for use in the generation of enzymatic polypeptides for animal feeds and nutrients |
| 07/04/2002 | US20020086370 Method of producing l-lysine |
| 07/04/2002 | US20020086369 Expression vectors for use as tools in human therapeutics and diagnostics |
| 07/04/2002 | US20020086367 Novel secreted proteins |
| 07/04/2002 | US20020086366 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 2 promoter and terminator |
| 07/04/2002 | US20020086365 Nucleotide sequencs which code polypeptide for use in the treatment of psychological and neurological disorders |
| 07/04/2002 | US20020086363 G-protein parathyroid hormone receptor HLTDG74 |
| 07/04/2002 | US20020086362 Human amine receptor |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086359 Polypeptide for use in controlling signal transduction |
| 07/04/2002 | US20020086358 Enzyme isolated from a Bifidobacterium |
| 07/04/2002 | US20020086357 32591, a novel human GTPase activating molecule and uses therefor |
| 07/04/2002 | US20020086356 Preferential nucleotide sequences for controlling preferential ribonucleic acids; for use in therapeutic genomics; for gene therapy |
| 07/04/2002 | US20020086355 Nucleotide sequences coding enzymatic polypeptide for use in cosmetics, pharmacology and food processing |
| 07/04/2002 | US20020086352 Methods for expressing endostatin protein |
| 07/04/2002 | US20020086350 Microbial swollenin protein, dna sequences encoding such swollenins and method of producing such swollenins |
| 07/04/2002 | US20020086349 Nucleic acid molecules which code proteins which mediate the adhesion of neisseria cells to human cells |
| 07/04/2002 | US20020086342 Detection of enzyme inhibitors; obtain sample, incubate with modulator, monitor sample for dephosphorylation, compare to control |
| 07/04/2002 | US20020086332 Method of reducing bacterial proliferation |
| 07/04/2002 | US20020086328 Gdu, a novel signalling protein |
| 07/04/2002 | US20020086326 Methods and kits for isolating biological target materials using silica magnetic particles |
| 07/04/2002 | US20020086325 Microarrays for use in the detection of preferential compounds in sample |
| 07/04/2002 | US20020086324 Process for high throughput DNA methylation analysis |
| 07/04/2002 | US20020086322 Microarray-based analysis of polynucleotide sequence variations |
| 07/04/2002 | US20020086320 Detecting prostate cancer gene in test sample; obtain nucleotide sequence sample, incubate with probe, detect signal for from probes bound to target sequences |
| 07/04/2002 | US20020086317 Sequencing preferential nucleotide sequences; obtain nucleotide sequences, insert preferential heavy elements into compound, insert into microscope, monitor base preferential labels, determine nucleotide sequence |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086315 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 07/04/2002 | US20020086312 Screening for modulator of receptor binding activity; obtain cells, incubate with modulator, monitor cell response |
| 07/04/2002 | US20020086311 Detecting mmutation in gene for enzymatic polypeptide; obtain nucleotide squences sample, amplify sequences, detect duplication of nucleotide sequences, the presence of the duplication indicates preferential genetic disorder |
| 07/04/2002 | US20020086310 Detecting target of microbiocide; obtain nucleotide sequences, insert into vector, induce expression of gene, compare propagation of cells, determine antibiotic resistance |
| 07/04/2002 | US20020086306 Detecting preferential nucleotide sequences in sample; obtain sample containing nucleotide sequences, incubate with primer, amplify, hybridize signal probe, detect signal |
| 07/04/2002 | US20020086305 Human c-Maf compositions and methods of use thereof |
| 07/04/2002 | US20020086304 Method of isolation of regulated virulence determinants from bacterial pathogens |
| 07/04/2002 | US20020086303 Nucleotide sequences coding polypeptides for use in the diangosis and treatment of tumors |
| 07/04/2002 | US20020086302 Nucleotide sequences coding proteins for use in the treatment of bone, cell diffentiation and proliferation disorders |
| 07/04/2002 | US20020086301 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086299 Methods of screening potential translational regulatory elements of messenger RNA |
| 07/04/2002 | US20020086298 DNA encoding inward rectifier, G-protein activated, mammalian, potassium KGA channel and uses thereof |
| 07/04/2002 | US20020086297 Gene alteration in the gene for the Gbeta3-subunit of the human G protein |
| 07/04/2002 | US20020086296 26583, a novel serine/threonine phosphatase and uses therefor |
| 07/04/2002 | US20020086292 Generating libraries of hybrid polynucleotide sequences; obtain single-stranded nucleotide sequences, incubate with primers, amplify nucleotide sequences, recover amplified nucleotide sequences |
| 07/04/2002 | US20020086291 Analyzing structural properties of nucleotide sequences; obtain nucleotide sequences, hydrolyze nucleotide sequences, separate and detect nucleotide sequences |
| 07/04/2002 | US20020086289 Screening sample for the presence of multiple microorganisms; obtain sample, incubate with multiple probes, monitor hybridization pattern, detect microorganismal nucleotide sequences |
| 07/04/2002 | US20020086279 Protein activity screening of clones having DNA from uncultivated microorganisms |
| 07/04/2002 | US20020086033 Pestivirus mutants and vaccines containing the same |
| 07/04/2002 | US20020086032 Administering immunogenic dose of attenuated bacteria comprising altered DNA adenine methylase (Dam) activity relative to a wild-type bacteria for generating immune response and produce antibodies |
| 07/04/2002 | US20020086031 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 07/04/2002 | US20020086024 RatB polypeptides and DNA (RNA) encoding ratB polypeptides producing such polypeptides by recombinant techniques; utilizing ratB polypeptides to screen for antibacterial compounds. |
| 07/04/2002 | US20020086023 Streptococcal streptolysin S vaccines |
| 07/04/2002 | US20020086019 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020086014 Human sequence antibody that specifically binds to human CTLA-4; nucleic acid encoding a heavy chain of a human sequence antibody; polyvalent complex; transgenic non-human; treating an autoimmune disease |
| 07/04/2002 | US20020086011 Administering an effective amount of an OX-2 protein or a nucleic acid encoding an OX-2 protein; use to suppress an immune response and to prevent or treat autoimmune disease, especially arthritis. |
| 07/04/2002 | US20020086008 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 07/04/2002 | US20020086007 Angiogenesis-inhibiting peptides and proteins and methods of use |
| 07/04/2002 | US20020086004 Especially wherein said angiogenic factor is an endothelial cell growth factor chosen from the FGF family of growth factors and the VEGF family of growth factors. |
| 07/04/2002 | US20020085999 Marek's disease virus genes and their use in vaccines for protection against marek's disease |
| 07/04/2002 | US20020085989 Process of making a compound by forming a polymer from a template drug |